Jazz Pharmaceuticals
JAZZ
#1899
Rank
ยฃ7.74 B
Marketcap
ยฃ127.39
Share price
1.67%
Change (1 day)
31.99%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ5.55 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ5.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ6.31 B5%
2023-12-31ยฃ6.00 B-6.18%
2022-12-31ยฃ6.40 B3.76%
2021-12-31ยฃ6.17 B192.58%
2020-12-31ยฃ2.11 B13.96%
2019-12-31ยฃ1.85 B-3.92%
2018-12-31ยฃ1.92 B8.04%
2017-12-31ยฃ1.78 B-24.7%
2016-12-31ยฃ2.36 B102.45%
2015-12-31ยฃ1.17 B-7.42%
2014-12-31ยฃ1.26 B121.15%
2013-12-31ยฃ0.57 B9.29%
2012-12-31ยฃ0.52 B1237.14%
2011-12-31ยฃ39.1 M-42.6%
2010-12-31ยฃ68.13 M-38.82%
2009-12-31ยฃ0.11 B-22.41%
2008-12-31ยฃ0.14 B86.92%
2007-12-31ยฃ76.79 M-61.52%
2006-12-31ยฃ0.19 B21.58%
2005-12-31ยฃ0.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Endo International
ENDPQ
ยฃ8.80 B 58.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
ยฃ45.23 B 714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ46.94 B 745.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
ยฃ24.47 B 340.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel